Evidence map›Paper›PMID 20167432›Full record

ArticlePain2010

NMDA-receptor activation and nitroxidative regulation of the glutamatergic pathway during nociceptive processing.

Zhoumou Chen, Carolina Muscoli, Tim Doyle, L Bryant, Salvatore Cuzzocrea, Vincenzo Mollace, Rosanna Mastroianni, Emanuela Masini, Daniela Salvemini

Abstract read
In one paragraph

Article in Pain, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
  5. Honokiol-RichAntioxidants (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. An integrated review on new targets in the treatment of neuropathic pain.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2019
    Review
  13. Review
  14. Article
  15. Histamine HBritish journal of pharmacology · 2017
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Zhoumou ChenDepartment of Pharmacological and Physiological Science, Saint Louis University School of Medicine, 1402 South Grand Blvd., St. Louis, MO 63104, USA IRCCS San Raffaele Pisana, Rome, Italy Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Italy Department of Preclinical and Clinical Pharmacology, University of Florence, Italy.
Carolina Muscoli
Tim Doyle
L Bryant
Salvatore Cuzzocrea
Vincenzo Mollace
Rosanna Mastroianni
Emanuela Masini
Daniela Salvemini
University of Florence · ITIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleSaint Louis University · USUniversity of Messina · IT

Funding

Role of peroxynitrite in morphine hyperalgesia and toleranceR01DA024074 · NIDA · SAINT LOUIS UNIVERSITY · PI SALVEMINI, DANIELA · 2008 to 2012
$1.7M
Role of ceramide in morphine hyperalgesia and toleranceR21DA023056 · NIDA · SAINT LOUIS UNIVERSITY · PI SALVEMINI, DANIELA · 2008 to 2009
$392k
NIDA NIH HHS 1 R01 DA024074-01A1NIDA NIH HHS 1 R21 DA023056-01A2NIDA NIH HHS R01 DA024074NIDA NIH HHS R21 DA023056
6 · The paper itself

Abstract

The role of peroxynitrite (PN) as a mediator of nociceptive signaling is emerging. We recently reported that the development of central sensitization that follows the intraplantar injection of carrageenan in rats is associated with spinal PN synthesis. We now demonstrate that a significant pathway through which spinal PN modulates central sensitization is post-translational tyrosine nitration of key proteins involved in the glutamatergic pathway, namely glutamate transporter GLT-1 and glutamine synthetase (GS). We also reveal that spinal activation of the N-methyl-d-aspartate (NMDA) receptor provides a source of PN in this setting. Intraplantar injection of carrageenan led to the development of thermal hyperalgesia as well as nitration of GLT-1 and GS in dorsal horn tissues. Pretreatment with the PN decomposition catalyst FeTM-4-PyP(5+) [Fe(III)5,10,15,20-tetrakis(N-methylpyridinium-4-yl)porphyrin] or the NMDA receptor antagonist MK-801 blocked the development of hyperalgesia. Carrageenan-induced hyperalgesia was also associated with nitration and inactivation of spinal mitochondrial superoxide dismutase (MnSOD) known to provide a critical source of PN during central sensitization. Nitration of GLT-1 and GS contributes to central sensitization by enhancing glutamatergic neurotransmission. Our results support the critical role of nitroxidative stress in the development of hyperalgesia and suggest that post-translational nitration of enzymes and transporters linked to glutamatergic neurotransmission represent a novel mechanism of central sensitization.

Indexed as

Signal TransductionAnimalsGlutamic AcidHyperalgesiaMaleOxidation-ReductionPeroxynitrous AcidRatsRats, Sprague-DawleySpinal CordGlutamic AcidPeroxynitrous Acid

Identifiers

PMID20167432
PMCPMC2837917
OpenAlexW1981803317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.